Señales en vivo de KDNY | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (10 ago 2023 @ 16:00):

Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases...

Stats
Volumen de hoy	3.28M
Volumen promedio	2.04M
Capitalización de mercado	2.71B
EPS	$0 ( 2024-02-26 )
Próxima fecha de ganancias	( $0 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-12.47
ATR14	$0.453 (1.12%)

Insider Trading

Date	Person	Action	Amount	type
2023-08-11	Thomas Dolca	Sell	13 300	Common Stock
2023-08-11	Thomas Dolca	Sell	23 522	Stock Option (Right to Buy)
2023-08-11	Thomas Dolca	Sell	5 948	Stock Option (Right to Buy)
2023-08-11	Thomas Dolca	Sell	13 300	Stock Option (Right to Buy)
2023-08-11	Oxtoby Andrew	Sell	160 000	Stock Option (Right to Buy)

INSIDER POWER
-96.04
Last 99 transactions
Buy: 289 232 \| Sell: 10 194 260

Volumen Correlación

Largo: 0.28 (neutral)

Corto: 0.00 (neutral)

Signal:(78.495) Neutral

Aduro Biotech Inc Correlación

10 Correlaciones Más Positivas
KIN	0.983
SCPL	0.975
ABST	0.973
BWC	0.972
CDRO	0.971
NXGN	0.971
TXRH	0.962
IMGN	0.961
SRRA	0.961
ISEE	0.956

10 Correlaciones Más Negativas
CYAN	-0.967
PEAR	-0.96
SSP	-0.958
AUPH	-0.958
PYR	-0.957
SABR	-0.955
QDEL	-0.954
PENN	-0.953
PTE	-0.952
BRQS	-0.952

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aduro Biotech Inc Correlación - Moneda/Commodity

0.39
( neutral )

0.67
( moderate )

-0.22
( neutral )

-0.27
( neutral )

0.05
( neutral )

0.70
( moderate )

Aduro Biotech Inc Finanzas

Annual	2022
Ingresos:	$6.13M
Beneficio Bruto:	$4.41M (71.90 %)
EPS:	$-2.87

FY	2022
Ingresos:	$6.13M
Beneficio Bruto:	$4.41M (71.90 %)
EPS:	$-2.87

FY	2021
Ingresos:	$51 625.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.00226

FY	2020
Ingresos:	$827 000
Beneficio Bruto:	$827 000 (100.00 %)
EPS:	$-6.20

Financial Reports:

No articles found.

Aduro Biotech Inc

Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. Its product candidates also include BION-1301, an anti-APRIL monoclonal antibody is being evaluated in a Phase I/II trial for IgA nephropathy; and CHK-336, an oral small molecule LDHA inhibitor for the treatment of primary hyperoxaluria, as well as research programs for other rare and severe chronic kidney diseases. Chinook Therapeutics, Inc. is headquartered in Seattle, Washington.

Actualizaciones en tiempo real para Aduro Biotech Inc [KDNY]

Upcoming Earnings Alert